```json
{
"content": [
{
"type": "paragraph",
"content": "Intravascular Lithotripsy (IVL) is a minimally invasive technology used to treat calcified coronary and peripheral artery disease by delivering targeted sonic pressure waves to fracture plaque. As a critical innovation in interventional cardiology, the IVL market size is projected to expand significantly, driven by rising prevalence of atherosclerosis and advancements in procedural efficiencies. The global Intravascular Lithotripsy market forecast underscores robust industry expansion, with key players leveraging technological differentiation to address unmet clinical needs."
},
{
"type": "chart",
"chartType": "segment-stacked",
"data": {
"segments": ["North America", "Europe", "Asia-Pacific"],
"periods": ["2021", "2022", "2023", "2024", "2025", "2026", "2027", "2028", "2029", "2030", "2031", "2032", "2033"],
"values": [
[120, 128, 135, 142, 150, 158, 166, 175, 184, 193, 202, 212, 222], // North America
[80, 84, 88, 92, 96, 100, 104, 108, 112, 116, 120, 125, 130], // Europe
[50, 53, 57, 61, 65, 69, 73, 78, 83, 88, 93, 98, 103] // Asia-Pacific
]
}
},
{
"type": "paragraph",
"content": "The IVL industry growth outlook indicates a compound annual growth rate (CAGR) of 17.5% from 2026 to 2033, fueled by macro drivers such as aging populations, rising obesity rates, and adoption of minimally invasive therapies. Regulatory harmonization across major markets and technological shifts—including next-generation IVL systems with real-time imaging integration—are reshaping competitive intensity. While North America dominates the market due to high adoption rates and advanced healthcare infrastructure, Asia-Pacific is the fastest-growing region (CAGR ~23%), spurred by expanding private healthcare access and favorable reimbursement policies."
}
]
}
```
